Business · 17/09/2007Updated: 10/17/2026 · 1 min read
FDA Reopens Comment Period for Draft Guidance on In Vitro Diagnostic Multivariate Index Assays
Summary
The Food and Drug Administration (FDA) is extending the comment period for its revised draft guidance on In Vitro Diagnostic Multivariate Index Assays until October 17, 2007, to allow for sufficient stakeholder input.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →